Shilpa Medicare Ltd (SHILPAMED) is currently trading at 297.10 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Shilpa Medicare Limited is a leader in the pharmaceutical sector with over 35 years of experience, focusing on Active Pharmaceutical Ingredients (APIs), formulations, and biologics, particularly in oncology. The company demonstrated significant financial growth for 1H FY26, showcasing quarterly revenues of INR 372 crores (7% YoY increase) and strong EBITDA margins at 30%. Their robust biotechnology division is advancing biosimilars and Novel Biological Entities (NBEs), positioning Shilpa as a rising player in innovative biologic therapies. Shilpa is pursuing aggressive capex investments in API capacity expansion and biologics, aiming to capture growth opportunities in both Indian and international markets. Strategic collaborations, such as the partnership with Orion Corporation for human albumin commercialization in Europe, highlight Shilpa's strategic vision for expansion and innovation.

Over the past 52 weeks, Shilpa Medicare Ltd has traded between a low of ₹265.25 and a high of ₹501.60. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Shilpa Medicare Ltd has a market capitalization of approximately 5,754.02. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Shilpa Medicare Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 37.19 and operates in the Pharmaceuticals sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

You can buy shares of Shilpa Medicare Ltd (SHILPAMED) through any SEBI-registered stockbroker in India. A demat and trading account are required to place buy or sell orders on stock exchanges such as NSE or BSE. Shares are credited to the demat account as per the exchange settlement cycle.

Based on its market capitalization of 5,754.02 Cr, Shilpa Medicare Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Shilpa Medicare Ltd operates in the Pharmaceuticals sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Shilpa Medicare Ltd is 37.19. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Shilpa Medicare Ltd pays dividends with a current dividend yield of 0.17%. Dividend-paying stocks may provide periodic income in addition to potential long-term capital appreciation.

Key risks associated with Shilpa Medicare Ltd include sector-specific challenges in the Pharmaceuticals industry, regulatory changes, competitive pressures, company-level financial performance, overall market volatility, and broader macroeconomic factors that can impact stock prices.